Novartis Investigative Site

Burke, Virginia 22015

0 studies enrolling now · 3 studies all time

What they study most

Atherosclerosis, Cardiovascular Disease, Chronic Obstructive Pulmonary Disease (COPD), Type 2 Diabetes Mellitus

Studies at this site

• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Long Term Safety Study of NVA237 vs QAB149 in COPD Patients — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early